Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Acceptability of Lumbar Puncture Among Patients, Caregivers, and Providers in Lusaka, Zambia
Global Health and Neuroepidemiology
Global Health Posters (7:00 AM-5:00 PM)
010

Meningitis mortality is disproportionately high for Zambia’s sociodemographic index. We examined barriers to meningitis care in Lusaka. Poor LP uptake is a barrier, yet little is known about LP acceptability.

To characterize lumbar puncture (LP) acceptability among patients/caregivers and providers in Zambia.

Audio-recorded face-to-face and telephone interviews were conducted with patients admitted with meningitis or their caregivers (n=25), doctors (n=8), and nurses (n=8) at University Teaching Hospital (UTH). Patient/caregiver interviews addressed meningitis treatment, understanding of meningitis, and biomedical care. Provider interviews focused on care of meningitis patients and inpatient care challenges. A framework approach was used for analysis.

Patients/caregivers knew that LP collected fluid from the back but could not describe procedure benefits. They viewed LP as a dangerous procedure associated with death, to be avoided at all costs. Caregivers who consented to LP often knew someone who had survived LP. LP consent implied accepting blame for patient mortality, though this was mitigated if death was viewed as “God’s will”. Wives felt they lacked capacity to consent for LP, and deferred to extended family, which delayed care.

Doctors and nurses recognized poor community understanding of LP but cited multiple barriers to bedside counseling, including competing clinical demands, limited patient/caregiver education, and language. Limited counseling did not overcome strongly negative LP views, as caregivers often remained with misconceptions after consent and LP refusal was sometimes followed by immediate hospital discharge. Consent was often obtained late in the patient’s illness and often several days after initiation of empiric antibiotics. Preceding antibiotic therapy was often not considered when interpreting results.

Poor LP uptake reflects patient/caregiver misgivings, perceived blame for potential poor outcomes, and ineffective bedside education.  Complementary efforts addressing patient, provider, and community concerns are needed to improve LP acceptability and utility in Zambia.   

Authors/Disclosures
Melissa Elafros, MD, PhD (Michigan Medicine)
PRESENTER
The institution of Dr. Elafros has received research support from National Institute of Neurologic Disorders and Stroke . The institution of Dr. Elafros has received research support from National Center for Advancing Translational Sciences. The institution of Dr. Elafros has received research support from National Institute of Diabetes and Digestive and Kidney Diseases .
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Gretchen L. Birbeck, MD, MPH, DTMH, FAAN (University of Rochester/CHET) An immediate family member of Dr. Birbeck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Birbeck has a non-compensated relationship as a Ambassador for Zambia with RSTMH that is relevant to AAN interests or activities.
Mashina Chomba, MBChB (University of Zambia) Dr. Chomba has nothing to disclose.
No disclosure on file
Michelle P. Kvalsund, DO (University of Rochester) Dr. Kvalsund has nothing to disclose.
Izukanje Sikazwe No disclosure on file
Deanna Saylor, MD, MHS (Johns Hopkins Hospital) The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from National Multiple Sclerosis Society. The institution of Dr. Saylor has received research support from American Academy of Neurology. The institution of Dr. Saylor has received research support from United States Department of State. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and Educational Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.
Peter Winch (Johns Hopkins University) No disclosure on file